Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Acer Therapeutics Inc./ 10-Q

Quarterly Report · 10-Q

Acer Therapeutics Inc.

Quarterly Report

Filed Nov 20, 2023Accepted Nov 20, 2023, 11:51 AM ESTCIK 1069308Accession 0000950170-23-065159
View company →Permanent SEC source ↗
Share

Company context

Historical securities (2)
ACERWNASDAQ · WARRANT · Historical · closed Apr 6, 2018OPXAWNASDAQ · WARRANT · Historical · closed Jan 15, 2025

Recent company filings

  1. 15-12G filingNov 30, 2023
  2. EFFECT filingNov 24, 2023
  3. EFFECT filingNov 24, 2023
  4. 4 filingNov 20, 2023
  5. 4 filingNov 20, 2023

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗